These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 21483404)

  • 1. Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment.
    Pellicano R; Fagoonee S; Astegiano M; Morgando A; Cisarò F; Rizzetto M
    Minerva Med; 2011 Apr; 102(2):169-70. PubMed ID: 21483404
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.
    Pellicano R; Astegiano M; Smedile A; Saracco G; Berrutti M; Morgando A; Fadda M; Repici A; Fagoonee S; Rizzetto M
    Panminerva Med; 2008 Sep; 50(3):259-60. PubMed ID: 18927531
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study.
    Berrutti M; Astegiano M; Smedile A; Fagoonee S; Rizzetto M; Pellicano R
    Panminerva Med; 2010 Dec; 52(4):361-2. PubMed ID: 21183897
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori?
    Tokoro C; Inamori M; Koide T; Iida H; Sakamoto Y; Endo H; Hosono K; Takahashi H; Yoneda M; Yasuzaki H; Ogawa M; Abe Y; Kubota K; Saitou S; Kawana I; Matsuda R; Takahashi D; Nakajima A
    Hepatogastroenterology; 2010; 57(104):1645-9. PubMed ID: 21443136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
    Sánchez-Delgado J
    Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
    Sasaki M; Ogasawara N; Utsumi K; Kamiya T; Kataoka H; Tanida S; Mizoshita T; Shimura T; Hirata Y; Kasugai K; Joh T
    Methods Find Exp Clin Pharmacol; 2010 May; 32(4):243-6. PubMed ID: 20508872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differences between European guideline and planned S3 guideline of DGVS. Need for Helicobacter pylori eradication to be decided on an individual basis].
    MMW Fortschr Med; 2008 Jun; 150(23):48-9. PubMed ID: 18578071
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux masquerader: acute Helicobacter pylori infection in neonates and infants.
    Frem JC; Gold BD; Shehata BM; Cole CR
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):589-92. PubMed ID: 18493216
    [No Abstract]   [Full Text] [Related]  

  • 13. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.
    Gisbert JP;
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1484-5; author reply 1486. PubMed ID: 22582841
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
    Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
    Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
    Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
    Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.